Venture Catalysts Announces Full Exit from Pee Safe, Delivering 9.60x Return and 30.53 Percent XIRR

 

Venture Catalysts Announces Full Exit from Pee Safe, Delivering 9.60x Return and 30.53 Percent XIRR

 

New Delhi, India, March 17 2026: Venture Catalysts, India’s leading integrated incubator and early-stage investment platform, has announced that it has taken full exit from Pee Safe following the women’s hygiene and wellness brand’s recent USD 32 million funding led by global healthcare-focused private equity firm OrbiMed.

 

The secondary component of the round enabled liquidity for select early investors, including Venture Catalysts, converting long term value creation into cash returns. This outcome underscores the firm’s strategy of identifying category creators early and supporting them through scale until institutional capital participation and liquidity events emerge.

 

Venture Catalysts first backed Pee Safe in August 2017, supporting the company at an early inflection point as it expanded from a focused toilet hygiene proposition into a broad personal hygiene and wellness portfolio. In June 2017, the company had raised pre series capital that included Venture Catalysts, highlighting the firm’s focus on founders with clarity of mission and speed of execution. At the time of investment, organised women’s hygiene innovation was still nascent in India, reflecting Venture Catalysts’ ability to spot underserved consumer categories ahead of mainstream investor attention.

 

The exit was completed in January 2026, generating a 9.60 multiple on invested capital and an XIRR of 30.53 percent for the fund and its limited partners. Beyond performance metrics, the transaction demonstrates Venture Catalysts’ ability to take companies from first cheque to credible liquidity, a key expectation for LPs evaluating venture as an asset class in India. The journey from early conviction capital to realized exit reinforces the platform’s hands-on incubation model and disciplined early entry strategy.

 

This realization reinforces Venture Catalysts’ disciplined approach to selecting founder-led consumer brands with clear unit economics, repeat purchase behaviour, and the ability to build distribution across channels. Pee Safe has scaled with an omnichannel model, with products available through more than 50,000 offline retail touchpoints across over 100 cities, alongside e-commerce, quick commerce platforms, and its direct to consumer channels. The brand has also recorded consistent growth, expanding at approximately 45–50 percent year-on-year over the last two years.

 

The OrbiMed led round brings Pee Safe’s total funding to USD 45.55 million, with investors including Zerodha and Natco Pharma continuing to be part of the company’s investor base. The company plans to use the capital to expand offline retail presence, strengthen brand led marketing, and deepen reach across quick commerce and major online marketplaces.

 

Dr Apoorva Ranjan Sharma, Founder, Venture Catalysts, said, “This exit is a validation of patient early stage investing where we back founders before the market agrees. Pee Safe built category depth, distribution muscle, and brand trust. Delivering cash returns, not just markups, strengthens our promise to LPs and energizes our next cycle of investments for everyone involved today.”

 

Vikas Bagaria, Founder, Pee Safe, said, “Venture Catalysts believed in our mission early and were part of our first fund raise. As we welcome OrbiMed and scale faster, we are proud that early partners can realize meaningful outcomes. We see this as proof that strong brands can be built from India.”

 

Venture Catalysts will continue to partner with entrepreneurs across consumer, healthcare, and technology, with a focus on scalable businesses that can compound through resilient fundamentals and credible paths to liquidity. The firm remains focused on identifying high-potential startups at formative stages, where strategic capital and ecosystem support can meaningfully accelerate long-term value creation. It also views exits as an integral part of portfolio stewardship, reinforcing confidence among founders and investors in the evolving Indian startup ecosystem.